• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转化酶开门营业:结构洞察亚结构域动力学。

Angiotensin-converting enzyme open for business: structural insights into the subdomain dynamics.

机构信息

Department of Biology and Biochemistry, University of Bath, Bath, UK.

Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

出版信息

FEBS J. 2021 Apr;288(7):2238-2256. doi: 10.1111/febs.15601. Epub 2020 Nov 2.

DOI:10.1111/febs.15601
PMID:33067882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8048788/
Abstract

Angiotensin-1-converting enzyme (ACE) is a key enzyme in the renin-angiotensin-aldosterone and kinin systems where it cleaves angiotensin I and bradykinin peptides, respectively. However, ACE also participates in numerous other physiological functions, can hydrolyse many peptide substrates and has various exo- and endopeptidase activities. ACE achieves this complexity by containing two homologous catalytic domains (N- and C-domains), which exhibit different substrate specificities. Here, we present the first open conformation structures of ACE N-domain and a unique closed C-domain structure (2.0 Å) where the C terminus of a symmetry-related molecule is observed inserted into the active-site cavity and binding to the zinc ion. The open native N-domain structure (1.85 Å) enables comparison with ACE2, a homologue previously observed in open and closed states. An open S _S'-mutant N-domain structure (2.80 Å) includes mutated residues in the S and S' subsites that effect ligand binding, but are distal to the binding site. Analysis of these structures provides important insights into how structural features of the ACE domains are able to accommodate the wide variety of substrates and allow different peptidase activities. DATABASE: The atomic coordinates and structure factors for Open nACE, Open S2_S'-nACE and Native G13-cACE structures have been deposited with codes 6ZPQ, 6ZPT and 6ZPU, respectively, in the RCSB Protein Data Bank, www.pdb.org.

摘要

血管紧张素转化酶(ACE)是肾素-血管紧张素-醛固酮和激肽系统中的关键酶,分别切割血管紧张素 I 和缓激肽肽。然而,ACE 还参与许多其他生理功能,可以水解许多肽底物,并具有各种外肽酶和内肽酶活性。ACE 通过包含两个同源催化结构域(N-和 C-结构域)来实现这种复杂性,这两个结构域表现出不同的底物特异性。在这里,我们展示了 ACE N-结构域的第一个开放构象结构和一个独特的封闭 C-结构域结构(2.0Å),其中观察到对称相关分子的 C 末端插入活性位点腔并与锌离子结合。开放的天然 N-结构域结构(1.85Å)使我们能够与 ACE2 进行比较,ACE2 是以前在开放和封闭状态下观察到的同源物。开放的 S _S'-突变 N-结构域结构(2.80Å)包含在 S 和 S'亚位点中突变的残基,这些残基影响配体结合,但远离结合位点。这些结构的分析提供了重要的见解,了解 ACE 结构域的结构特征如何能够容纳各种底物并允许不同的肽酶活性。数据库:Open nACE、Open S2_S'-nACE 和 Native G13-cACE 结构的原子坐标和结构因子已分别以代码 6ZPQ、6ZPT 和 6ZPU 存入 RCSB 蛋白质数据库,www.pdb.org。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/12adc302f634/FEBS-288-2238-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/f264c4861606/FEBS-288-2238-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/87ebec795677/FEBS-288-2238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/007d7c269b5d/FEBS-288-2238-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/7b0b1e19078d/FEBS-288-2238-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/811c03a43434/FEBS-288-2238-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/3561f2903aeb/FEBS-288-2238-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/eecf1098a22d/FEBS-288-2238-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/80750ce7c0e9/FEBS-288-2238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/3acca194d408/FEBS-288-2238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/6dd50f4c7048/FEBS-288-2238-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/12adc302f634/FEBS-288-2238-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/f264c4861606/FEBS-288-2238-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/87ebec795677/FEBS-288-2238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/007d7c269b5d/FEBS-288-2238-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/7b0b1e19078d/FEBS-288-2238-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/811c03a43434/FEBS-288-2238-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/3561f2903aeb/FEBS-288-2238-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/eecf1098a22d/FEBS-288-2238-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/80750ce7c0e9/FEBS-288-2238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/3acca194d408/FEBS-288-2238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/6dd50f4c7048/FEBS-288-2238-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/426c/8048788/12adc302f634/FEBS-288-2238-g008.jpg

相似文献

1
Angiotensin-converting enzyme open for business: structural insights into the subdomain dynamics.血管紧张素转化酶开门营业:结构洞察亚结构域动力学。
FEBS J. 2021 Apr;288(7):2238-2256. doi: 10.1111/febs.15601. Epub 2020 Nov 2.
2
ACE-domain selectivity extends beyond direct interacting residues at the active site.ACE 结构域的选择性不仅局限于活性位点的直接相互作用残基。
Biochem J. 2020 Apr 17;477(7):1241-1259. doi: 10.1042/BCJ20200060.
3
Crystal structures of sampatrilat and sampatrilat-Asp in complex with human ACE - a molecular basis for domain selectivity.与人血管紧张素转化酶复合物的结构研究——sampatrilat 和 sampatrilat-Asp 结构域选择性的分子基础
FEBS J. 2018 Apr;285(8):1477-1490. doi: 10.1111/febs.14421. Epub 2018 Mar 8.
4
Structural basis for the C-domain-selective angiotensin-converting enzyme inhibition by bradykinin-potentiating peptide b (BPPb).结构基础为 bradykinin-potentiating peptide b (BPPb) 对 C 域选择性血管紧张素转化酶抑制作用。
Biochem J. 2019 May 31;476(10):1553-1570. doi: 10.1042/BCJ20190290.
5
Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.人血管紧张素转换酶1对β-淀粉样肽水解作用的动力学及结构特征
FEBS J. 2016 Mar;283(6):1060-76. doi: 10.1111/febs.13647. Epub 2016 Feb 9.
6
Structural basis for the inhibition of human angiotensin-1 converting enzyme by fosinoprilat.福辛普利拉抑制人血管紧张素转化酶的结构基础。
FEBS J. 2022 Nov;289(21):6659-6671. doi: 10.1111/febs.16543. Epub 2022 Jun 16.
7
Advances in Structural Biology of ACE and Development of Domain Selective ACE-inhibitors.ACE 结构生物学的进展与域选择性 ACE 抑制剂的开发。
Med Chem. 2019;15(6):574-587. doi: 10.2174/1573406415666190514081132.
8
The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition.血管紧张素转换酶突变对N结构域选择性抑制的动力学和动态学的影响。
FEBS J. 2016 Nov;283(21):3941-3961. doi: 10.1111/febs.13900. Epub 2016 Oct 5.
9
Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors.选择性血管紧张素转换酶抑制剂的对接考虑因素。
Molecules. 2020 Jan 11;25(2):295. doi: 10.3390/molecules25020295.
10
Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.血管紧张素转换酶与底物促性腺激素释放激素之间的模拟相互作用:对结构域选择性的新见解。
Biochemistry. 2007 Jul 31;46(30):8753-65. doi: 10.1021/bi700253q. Epub 2007 Jul 3.

引用本文的文献

1
DrugGen enhances drug discovery with large language models and reinforcement learning.DrugGen利用大语言模型和强化学习提升药物研发。
Sci Rep. 2025 Apr 18;15(1):13445. doi: 10.1038/s41598-025-98629-1.
2
Dimerization and dynamics of angiotensin-I converting enzyme revealed by cryoEM and MD simulations.通过冷冻电镜和分子动力学模拟揭示血管紧张素转换酶的二聚化及动力学
bioRxiv. 2025 Jan 19:2025.01.09.632263. doi: 10.1101/2025.01.09.632263.
3
Clinical studies in Myxomatous Mitral Valve Disease dogs: most prescribed ACEI inhibits ACE2 enzyme activity and ARB increases AngII pool in plasma.

本文引用的文献

1
ACE-domain selectivity extends beyond direct interacting residues at the active site.ACE 结构域的选择性不仅局限于活性位点的直接相互作用残基。
Biochem J. 2020 Apr 17;477(7):1241-1259. doi: 10.1042/BCJ20200060.
2
Spontaneous Hinge-Bending Motions of Angiotensin I Converting Enzyme: Role in Activation and Inhibition.血管紧张素转换酶自发铰链弯曲运动:在激活和抑制中的作用。
Molecules. 2020 Mar 12;25(6):1288. doi: 10.3390/molecules25061288.
3
Structural basis for the C-domain-selective angiotensin-converting enzyme inhibition by bradykinin-potentiating peptide b (BPPb).
黏液瘤样二尖瓣疾病犬的临床研究:大多数常用的血管紧张素转换酶抑制剂(ACEI)会抑制血管紧张素转换酶2(ACE2)的酶活性,而血管紧张素Ⅱ受体阻滞剂(ARB)会增加血浆中血管紧张素Ⅱ(AngII)的含量。
Hypertens Res. 2025 Apr;48(4):1477-1490. doi: 10.1038/s41440-025-02109-y. Epub 2025 Jan 21.
4
Molecular basis of human angiotensin-1 converting enzyme inhibition by a series of diprolyl-derived compounds.一系列二脯氨酰衍生化合物对人血管紧张素1转换酶抑制作用的分子基础
FEBS J. 2025 Mar;292(5):1141-1158. doi: 10.1111/febs.17384. Epub 2025 Jan 6.
5
Deep learning-based discovery of compounds for blood pressure lowering effects.基于深度学习发现具有降血压作用的化合物。
Sci Rep. 2025 Jan 2;15(1):54. doi: 10.1038/s41598-024-83924-0.
6
Effects of Angiotensin-I-Converting Enzyme (ACE) Mutations Associated with Alzheimer's Disease on Blood ACE Phenotype.与阿尔茨海默病相关的血管紧张素转换酶(ACE)突变对血液中ACE表型的影响。
Biomedicines. 2024 Oct 21;12(10):2410. doi: 10.3390/biomedicines12102410.
7
Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors.血管紧张素转化酶(ACE)抑制剂结构基础研究进展。
Biosci Rep. 2024 Aug 28;44(8). doi: 10.1042/BSR20240130.
8
Food-Derived Up-Regulators and Activators of Angiotensin Converting Enzyme 2: A Review.食物来源的血管紧张素转换酶 2 的上调因子和激活剂:综述。
J Agric Food Chem. 2024 Jun 12;72(23):12896-12914. doi: 10.1021/acs.jafc.4c01594. Epub 2024 May 29.
9
ACE Phenotyping in Human Blood and Tissues: Revelation of ACE Outliers and Sex Differences in ACE Sialylation.人类血液和组织中的ACE表型分析:ACE异常值的揭示及ACE唾液酸化的性别差异
Biomedicines. 2024 Apr 23;12(5):940. doi: 10.3390/biomedicines12050940.
10
Carriers of Heterozygous Loss-of-Function ACE Mutations Are at Risk for Alzheimer's Disease.杂合功能丧失型ACE突变携带者有患阿尔茨海默病的风险。
Biomedicines. 2024 Jan 12;12(1):162. doi: 10.3390/biomedicines12010162.
结构基础为 bradykinin-potentiating peptide b (BPPb) 对 C 域选择性血管紧张素转化酶抑制作用。
Biochem J. 2019 May 31;476(10):1553-1570. doi: 10.1042/BCJ20190290.
4
The Plethora of Angiotensin-Converting Enzyme-Processed Peptides in Mouse Plasma.鼠血浆中丰富的血管紧张素转化酶处理肽。
Anal Chem. 2019 May 21;91(10):6440-6453. doi: 10.1021/acs.analchem.8b03828. Epub 2019 May 7.
5
Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design.分子基础多个奥美沙坦酯结合位点在 ACE C 域:对药物设计的影响。
J Med Chem. 2018 Nov 21;61(22):10141-10154. doi: 10.1021/acs.jmedchem.8b01309. Epub 2018 Nov 7.
6
Angiotensin-converting enzyme in innate and adaptive immunity.先天免疫和适应性免疫中的血管紧张素转换酶。
Nat Rev Nephrol. 2018 May;14(5):325-336. doi: 10.1038/nrneph.2018.15. Epub 2018 Mar 26.
7
Crystal structures of sampatrilat and sampatrilat-Asp in complex with human ACE - a molecular basis for domain selectivity.与人血管紧张素转化酶复合物的结构研究——sampatrilat 和 sampatrilat-Asp 结构域选择性的分子基础
FEBS J. 2018 Apr;285(8):1477-1490. doi: 10.1111/febs.14421. Epub 2018 Mar 8.
8
The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition.血管紧张素转换酶突变对N结构域选择性抑制的动力学和动态学的影响。
FEBS J. 2016 Nov;283(21):3941-3961. doi: 10.1111/febs.13900. Epub 2016 Oct 5.
9
Diffraction-geometry refinement in the DIALS framework.DIALS框架中的衍射几何精修
Acta Crystallogr D Struct Biol. 2016 Apr;72(Pt 4):558-75. doi: 10.1107/S2059798316002187. Epub 2016 Mar 30.
10
Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.人血管紧张素转换酶1对β-淀粉样肽水解作用的动力学及结构特征
FEBS J. 2016 Mar;283(6):1060-76. doi: 10.1111/febs.13647. Epub 2016 Feb 9.